1. Technologies to deliver therapeutics across the blood brain barrier - a common barrier for treating many brain diseases.
2. Technologies to help optimize therapies that are most likely to benefit selected patients - often referred to as personalized medicine.
3. Molecularly targeted therapies that target the abnormal pathways implicated in a variety of brain related disorders.